Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis

NCT03626376 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to enroll participants

Conditions

Herpes Simplex Virus Keratitis

Interventions

DRUG: oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily
DRUG: oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops

Sponsor

NYU Langone Health